Diabetes ‘action plan’ to tackle rise in Leicester
The latest diabetes figures have shown Leicester has one of the highest prevalence rates in the country at 8.98 per cent, well above the national average of 6.4 per cent.
However, the Leicester Changing Diabetes programme means a dedicated action plan is already underway as part of the global initiative developed to tackle urban diabetes.
Professor Melanie Davies CBE, Professor of Diabetes Medicine at the University of Leicester and Director of the Leicester Diabetes Centre, said:
“Type 2 diabetes represents a significant challenge, especially in our multi-ethnic city, but a challenge we are committed to meeting.
“The recent figures suggest there are more than 12 million people across the UK at risk of developing type 2 diabetes. Prevalence rates are still rising, so there’s obviously a lot of work to be done.”
The Cities Changing Diabetes programme drives awareness, education and treatment; and aims to unite key community stakeholders to unite and work together to improve the lives and health outcomes of people with diabetes.
Leicester now joins the likes of Rome, Copehnagan, Shanghi, Houston, Johannesburg, Mexico City, Shanghai, Tianjin and Vancouver to begin a global mission to reduce the prevalence of diabetes.
A hand-picked team of diabetes experts and researchers from the Leicester Diabetes Centre have joined forces to work collectively with stakeholders and partners on the Leicester Changing Diabetes initiative.
Professor Kamlesh Khunti, Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester and Co-Director at Leicester Diabetes Centre, added:
“We firmly believe the Cities Changing Diabetes programme here in Leicester will be a major boost to help us drive positive environmental changes that could reduce the risk of developing type 2 diabetes, as well as ensure those with the condition have the right level of support and education to manage it properly.”
Diabetes UK’s figures also suggest there are now almost 3.7 million people living with a diagnosis of the condition in the UK, an increase of 1.9 million since 1998.
Launched in 2014, Cities Changing Diabetes is a partnership programme initiated by the pharmaceutical company Novo Nordisk, University College London and Steno Diabetes Center Copenhagen to innovate new approaches to the prevention and management of type 2 diabetes in urban areas.